Centene — Denial Rates & Appeal Data
Compare against every insurer we track: denial rates ranked within reporting cohorts.
COVERAGE RIGHTS ROLLUP · CALCULATED FROM CENTENE PUBLIC DISCLOSURES
Rollup computed from Centene's own posted per-contract CMS-0057-F reports with full request counts (44 contracts across the Wellcare, Health Net, and Ambetter brands: 27 Medicare Advantage, 3 Medicaid plans incl. Health Net Medi-Cal, 14 marketplace issuers). Combined standard+expedited basis. By line: Medicare Advantage 12.4%, Medicaid 2.9%, marketplace (Ambetter) 24.7% standard denial. 69.0% of 40,160 reported appeals were overturned. Per-contract source links appear in the table below.
UNDERLYING SOURCE: CENTENE CMS-0057-F DISCLOSURE, CY2025 · VIEW SOURCE ↗ · METHODOLOGY
Metrics by contract / plan
| Contract / plan | Line | Requests | Denied | Appeals overturned | Avg decision | Source |
|---|---|---|---|---|---|---|
| CA-SHP · CA Health Net | Medicaid | 3,096,168 | 2.45% | 39.72% | 2d | Source |
| 49004 · FL Ambetter | Marketplace | 419,452 | 21% | 58.23% | 4d | Source |
| CA-CalViva · CA Health Net | Medicaid | 310,319 | 6.34% | 48.28% | 3d | Source |
| H3561 · CA Health Net | Medicare Advantage | 290,257 | 1.98% | 77.5% | 3d | Source |
| 29418 · TX Ambetter | Marketplace | 218,062 | 32.94% | 61.91% | 2d | Source |
| H0174 · TX Wellcare | Medicare Advantage | 192,173 | 19.3% | 94.76% | 5d | Source |
| H0562 · CA Health Net | Medicare Advantage | 184,541 | 1.94% | 77.17% | 3d | Source |
| H1032 · FL Wellcare | Medicare Advantage | 171,190 | 19.54% | 84.38% | 3d | Source |
| H2775 · NY Wellcare | Medicare Advantage | 151,140 | 16.46% | 94.24% | 4d | Source |
| H5087 · CA Wellcare | Medicare Advantage | 120,425 | 2.8% | 62.79% | 2d | Source |
| H1416 · IL,MS,AR,TN,SC Wellcare | Medicare Advantage | 106,623 | 16.19% | 94.97% | 4d | Source |
| 70111 · TN Ambetter | Marketplace | 104,566 | 22.76% | 68.5% | 2d | Source |
| 79222 · SC Ambetter | Marketplace | 99,318 | 21.46% | 56.8% | 4d | Source |
| 90714 · MS Ambetter | Marketplace | 91,950 | 21.52% | 33.84% | 2d | Source |
| H4506 · TX Wellcare | Medicare Advantage | 90,924 | 13.23% | 96.74% | 5d | Source |
| H4868 · NY Wellcare | Medicare Advantage | 90,696 | 20.84% | 92.72% | 4d | Source |
| 99723 · MO Ambetter | Marketplace | 89,747 | 22.81% | 57.57% | 2d | Source |
| 87226 · TX Ambetter | Marketplace | 89,666 | 32.48% | 60.06% | 2d | Source |
| H9730 · KY Wellcare | Medicare Advantage | 86,206 | 19.61% | 97.7% | 3d | Source |
| 34368 · KS Ambetter | Marketplace | 64,114 | 25.52% | 52.35% | 5d | Source |
| CA-ImperialValley · CA Health Net | Medicaid | 57,406 | 7.57% | 48.05% | 3d | Source |
| 35065 · IN Ambetter | Marketplace | 56,928 | 24.58% | 36.31% | 2d | Source |
| 91450 · AZ Ambetter | Marketplace | 54,027 | 25.99% | 37.3% | 4d | Source |
| 41047 · OH Ambetter | Marketplace | 52,991 | 28.38% | 56.92% | 4d | Source |
| H1112 · GA Wellcare | Medicare Advantage | 52,573 | 15.31% | 94.19% | 4d | Source |
| 77264 · NC Ambetter | Marketplace | 50,371 | 20.68% | 51.82% | 2d | Source |
| H0913 · NJ Wellcare | Medicare Advantage | 42,739 | 17.51% | 96.51% | 5d | Source |
| H7326 · SC Wellcare | Medicare Advantage | 32,752 | 14.59% | 97.82% | 4d | Source |
| H2491 · LA Wellcare | Medicare Advantage | 27,851 | 13.5% | 96.49% | 4d | Source |
| H5965 · WA Wellcare | Medicare Advantage | 26,621 | 18.46% | 97.58% | 5d | Source |
| H0029 · WA Wellcare | Medicare Advantage | 26,108 | 16.5% | 96.37% | 5d | Source |
| 90787 · LA Ambetter | Marketplace | 22,862 | 24.25% | 30.59% | 3d | Source |
| H5779 · IL Wellcare | Medicare Advantage | 14,880 | 16.63% | 95.14% | 4d | Source |
| H7323 · TX Wellcare | Medicare Advantage | 14,095 | 19.21% | 98.57% | 4d | Source |
| H4847 · SC Wellcare | Medicare Advantage | 13,731 | 14.75% | 95.74% | 4d | Source |
| H1914 · NC Wellcare | Medicare Advantage | 13,552 | 14.73% | 98.67% | 4d | Source |
| H0111 · GA Wellcare | Medicare Advantage | 12,773 | 15.66% | 94.26% | 4d | Source |
| H3975 · KY Wellcare | Medicare Advantage | 9,461 | 20.39% | 97.08% | 3d | Source |
| H4073 · NC Wellcare | Medicare Advantage | 8,937 | 13.56% | 100% | 4d | Source |
| 86382 · FL Ambetter | Marketplace | 6,402 | 18.28% | 64.15% | 4d | Source |
| H7518 · MO Wellcare | Medicare Advantage | 3,480 | 14.8% | 94.74% | 4d | Source |
| H0074 · MS Wellcare | Medicare Advantage | 3,134 | 16.94% | 100% | 4d | Source |
| H2816 · NY Wellcare | Medicare Advantage | 1,635 | 10.34% | 90% | 4d | Source |
| H0270 · AR Wellcare | Medicare Advantage | 850 | 15.88% | 93.75% | 4d | Source |
What these numbers mean for your denial
Coverage Rights calculated a 9.8% prior-authorization denial rate for the Medicare Advantage, Medicaid, and Marketplace contracts in 2025. In the calculated Medicare Advantage, Medicaid, and Marketplace contracts appeal scope, 69% were reversed — most denials that got challenged did not survive review. The underlying contract or plan figures were published by Centene; Coverage Rights performed the stated rollup.
The practical takeaway is narrower: an initial denial can change on review. These aggregate rates describe past decisions within the stated reporting scope; they do not predict the result of an individual appeal.
Your appeal deadline depends on your plan type
Centene runs several kinds of plans, and the appeal rules follow the plan, not the insurer. Find the ladder and the deadlines for yours:
Common questions
What is Centene's prior authorization denial rate?
Coverage Rights calculated a 9.8% prior-authorization denial rate for the Medicare Advantage, Medicaid, and Marketplace contracts reporting scope in 2025, using the public disclosure required by federal rule CMS-0057-F. Within the calculated Medicare Advantage, Medicaid, and Marketplace contracts appeal scope, 69% were overturned.
How do I appeal a Centene denial?
Start with the appeal instructions in Centene's denial notice. An independent external, fair-hearing, or Medicare review may be available after the required internal review, but eligibility depends on the coverage program, plan funding, denial type, regulating jurisdiction, and whether the notice says internal review is exhausted. Use the pathway tool before choosing the next reviewer.
Where do these numbers come from?
Coverage Rights calculated the displayed rollup from Centene's public CMS-0057-F disclosures for 2025. The methodology note identifies the included reporting scope and weighting or aggregation method; source links lead to the underlying insurer-published records.